E-cigs Work Better than Nicotine Replacement Therapy

Dr Linda Calabresi

writer

Dr Linda Calabresi

GP; Medical Editor, Healthed

Dr Linda Calabresi

It’s a controversial topic here in Australia.

But a new UK study, just published in the New England Journal of Medicine, gives strong support the role of e-cigarettes as a smoking cessation therapy.

The randomised controlled trial of almost 900 adult smokers wanting to quit found the one-year abstinence rate was 18% among the e-cigarette users compared to 9.9% among those who were randomised to receive nicotine replacement therapy.

Much of the difference could be attributed to adherence to the assigned product. After 12 months, 80% of the e-cigarette group were still using the device whereas only 9% of the alternative group were still taking their nicotine replacement therapy despite being able to choose between the patch, gum, lozenge, nasal spray, inhalator, mouth spray, mouth strip, and microtabs (or any combination of these).

PASSWORD RESET

Forgot your password or password not working? Please enter your email address. You will receive an email with the link to set a new password.

References

References:

Hajek P, Phillips-Waller A, Przulj D, Pesola F, Smith KM, Bisal N, et al. A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy.  N Engl J Med. 2019 Jan 30;  DOI: 10.1056/NEJMoa1808779 [Epub ahead of print]

Drazen JM, Morrissey S, Campion EW. The Dangerous Flavors of E-Cigarettes. N Engl J Med. 2019 Jan 30. DOI: 10.1056/NEJMe1900484 [Epub ahead of print]

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Deborah Bateson AM

Prof Deborah Bateson AM

The Natural Estrogen Debate: A Focus on Combined Oral Contraception

Prof Genie Pedagogos, Prof Richard MacIsaac & A/Prof Ralph Audehm

Prof Genie Pedagogos, Prof Richard MacIsaac & A/Prof Ralph Audehm

Panel Discussion on GLP1s for Chronic Kidney Disease in Type 2 Diabetes

Dr Gabby Mahoney

Dr Gabby Mahoney

Eczema Management Practical Tips

Prof Rodney Baber AM

Prof Rodney Baber AM

Menopausal Hormone Therapy and its Cardiovascular Benefits

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Share this

Share this

Dr Linda Calabresi

writer

Dr Linda Calabresi

GP; Medical Editor, Healthed

Test your knowledge

Recent articles

Latest GP poll

In your perception, how has Donald Trump's election to the US and related political discourse in the media concerning vaccine safety impact on your patients' willingness to follow Australian government recommended vaccinations?

Very negative impact

0%

Somewhat negative impact

0%

No noticeable impact

0%

Somewhat positive impact

0%

Very positive impact

0%

Find your area of interest

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Upcoming Healthed Webcast

MHT and its cardiovascular benefits

Tuesday 28th October, 7pm - 9pm AEDT

Speaker

Prof Rodney Baber AM

Obstetrician and Gynaecologist; Clinical Professor, Obstetrics and Gynaecology, The University of Sydney

We invite you to our next free webcast, where Prof Rod Baber will present on menopausal hormone therapy. Up to 4 hours CPD. RACGP & ACRRM accredited.